Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of a...
Prif Awduron: | Link, A, Bachmann, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2010
|
Eitemau Tebyg
-
Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.
gan: Jennings, G, et al.
Cyhoeddwyd: (2009) -
Anticytokine Autoantibodies and Fungal Infections
gan: Shanthi Kappagoda, et al.
Cyhoeddwyd: (2023-07-01) -
Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
gan: Vijaya Knight, et al.
Cyhoeddwyd: (2016-01-01) -
CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
gan: M.M. Venediktova, et al.
Cyhoeddwyd: (2011-09-01) -
CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
gan: M.M. Venediktova, et al.
Cyhoeddwyd: (2011-01-01)